Skip to main content

Peer Review reports

From: Degarelix therapy for prostate cancer in a real-world setting: experience from the German IQUO (Association for Uro-Oncological Quality Assurance) Firmagon® registry

Original Submission
20 Apr 2015 Submitted Original manuscript
Author responded Author comments
Resubmission - Version 2
Submitted Manuscript version 2
Author responded Author comments
Reviewed Reviewer Report
Reviewed Reviewer Report
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
2 Dec 2015 Editorially accepted
16 Dec 2015 Article published 10.1186/s12894-015-0116-4

You can find further information about peer review here.

Back to article page

BMC Urology

ISSN: 1471-2490

Contact us